(Boursier.com) — The Group Equasensa leading healthcare software publisher, announces changes to its Management Committee as of January 1, 2024.
Damien VALICON takes charge of the Pharmagest Division.
Damien VALICON, current Director of the Medical Solutions Division, is appointed Director of the Pharmagest Division. His mission will be to ensure the commercial dynamics of Pharmacie France and ASCA, to support the development of the European subsidiaries: PHARMAGEST Belgium, PHARMAGEST Luxembourg, PHARMAGEST Italia and the brand new PHARMAGEST Germany, as well as that of compliance. with MULTIMEDS and iMEDS and the new ATOOPHARM e-learning activity.
Dominique GOURSAUD takes over as Director of the Medical Solutions Division.
Dominique GOURSAUD, current Director of Commercial Strategy, is appointed Director of the Medical Solutions Division. His mission will be to continue the commercial organization work of the Division and to develop its service offering.
Noëlle STOULIG takes over the new Equasens Group Communications Department.
Noëlle STOULIG, current Marketing Director Europe Division Pharmagest, is appointed Director of Communications Group Equasens. Her mission will be to manage the Group’s overall communications strategy as well as its brand strategy, both internally and externally.
The other members of the Management Committee retain their functions.
The missions of Grégoire DE ROTALIER, Deputy General Manager and Director of the Axigate Link Division, Nicolas LAFON, Director of the Fintech Division, Franck FAVIER, Director of the e-Connect Division, Frédérique SCHMIDT, Administrative and Financial Director, and Sabrina GHARBI, Director of Human Resources, are not modified.
Denis SUPPLISSON, Managing Director of the Equasens Group, declared: “Now made up of a third of women, this new Management Committee’s mission is to intensify the growth dynamic and to be attentive to acquisition opportunities. , in accordance with the strategy defined by the Group’s Board of Directors.”